593
Views
16
CrossRef citations to date
0
Altmetric
Clinical Issues

Norms for CERAD Constructional Praxis Recall

, , , &
Pages 1345-1358 | Received 16 Feb 2011, Accepted 09 Aug 2011, Published online: 13 Oct 2011
 

Abstract

Recall of the four-item constructional praxis measure was a later addition to the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery. Norms for this measure, based on cognitively intact African Americans age ≥70 (Indianapolis-Ibadan Dementia Project, N = 372), European American participants age ≥66 (Cache County Study of Memory, Health and Aging, N = 507), and European American CERAD clinic controls age ≥50 (N = 182), are presented here. Performance varied by site; by sex, education, and age (African Americans in Indianapolis); education and age (Cache County European Americans); and only age (CERAD European American controls). Performance declined with increased age, within age with less education, and was poorer for women. Means, standard deviations, and percentiles are presented separately for each sample.

Acknowledgments

Support for this study was provided by National Institute on Aging grants R01 AG11380 (KW-B), P30 AG10133, P30AG028716, R01 AG09956, R01 AG026096, and Alzheimer's Association – IIRG-95-084 (FU, DR), U01 AG06790 and a consulting agreement with Bayer HealthCare Pharmaceuticals Inc. (GF).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.